Recruitics Wins 2019 Gold MarCom Award for Recruitment Marketing Strategy

Being honored for ‘Recruitment Marketing Strategy’ is validation of the data-centric approach that we take with talent acquisition to deliver the best possible results for our clients.

NEW YORK (PRWEB)
November 07, 2019

Recruitics, a data-centric recruitment marketing agency, was awarded a 2019 Gold MarCom Award in the category of “Recruitment Marketing Strategy” for their entry “Improving Recruitment Marketing ROI for Enterprise Healthcare Customer.” The case study showed the successful results that Recruitics delivered for a Fortune 50 healthcare company that included ongoing and seasonal hiring needs, as well as targeted campaigns.

Recruitics leveraged programmatic job advertising, sourcing and candidate engagement and targeted job advertising to exceed the client’s overall talent acquisition objectives. Through these efforts, the enterprise healthcare customer saw the following improvements, year-over-year:

• 
  20% improvement in applications from paid media
• 50% improvement in hires from paid media
• 26% improvement in application-to-hire conversion rate
• 0.5% decrease in CPA (cost-per-application)
• 21% decrease in CPH (cost-per-hire)

“This award is a recognition of our mission to make it easier for our clients to attract and hire great talent,” says Josh Gampel, Recruitics CEO. “Being honored for ‘Recruitment Marketing Strategy’ is validation of the data-centric approach that we take with talent acquisition to deliver the best possible results for our clients.”

The MarCom Awards honors excellence in marketing and communication while recognizing the creativity, hard work, and generosity of industry professionals. The organization was founded in 1995, and receives over 6,000 print and digital entries from around the world each year. You can view the full list of Gold award winners here: http://enter.marcomawards.com/winners/#/gold/2019

Gampel adds, “Thank you to MarCom for this tremendous recognition, to our team of industry experts that make it all happen, and to our clients that chose us for their recruitment marketing needs. We look forward to continuing to deliver best-in-class service in the recruitment marketing space.”

This MarCom Award win is the latest success in an exciting year for Recruitics, which included a ReSI Award for Most Innovative Recruitment Advertising Solution and the recent acquisition of KRT Marketing, a full-service recruitment marketing agency. The combination of the two companies’ expert teams, data, and technologies have established Recruitics as the industry’s preeminent recruitment marketing agency.

To download the Recruitics full case study, visit: https://hubs.ly/H0lGbxB0

For more information on Recruitics, visit: https://hubs.ly/H0lGbjh0

Follow Recruitics on Social Media:

https://www.linkedin.com/company/recruitics/

https://twitter.com/recruitics

https://www.facebook.com/Recruitics

https://www.instagram.com/recruitics/

Share article on social media or email:

Definitive Healthcare

“Over the past three years, Definitive Healthcare has grown to surpass the $100 million mark, so we are incredibly proud to secure placement on Deloitte’s Fast 500 list [for the third consecutive year], particularly as we scale upward,” said Jason Krantz, CEO of Definitive Healthcare.

FRAMINGHAM, Mass. (PRWEB)
November 07, 2019

Definitive Healthcare, the leading provider of data, intelligence, and analytics on the healthcare provider market, today announced it ranked #267 on Deloitte’s Technology Fast 500 list, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, software, and energy technology companies in North America. Based on fiscal year 2015 to 2018 revenue, Definitive Healthcare grew 413% during this three-year period.

In 2018 alone, Definitive Healthcare brought in 600 net new clients and the company now serves more than 2,500 customers, including 9 out of 10 of the U.S.’ top pharmaceutical, medical device, healthcare IT, and staffing companies. In addition, Definitive Healthcare expanded its talent base by adding more than 125 employees in 2018 and is on track to add 100 more by the end of 2019. Since 2015, Definitive Healthcare has expanded its product offering with the acquisition of three companies: U.S. Lifeline (2015), Billian’s HealthDATA (2016), and most recently the data services portion of HIMSS Analytics (2019).

“We are incredibly excited about the growth of Definitive Healthcare and appreciate the meaningful recognition by Deloitte for the third year in a row,” said Jason Krantz, CEO of Definitive Healthcare. “With 365 dedicated team members and an unwavering customer-focused strategy, we have been able to expand our data and analytics platform to meet the needs of our 2,500+ customers in a rapidly changing healthcare landscape. We are committed to helping our clients understand the complex healthcare market, so they can improve their market penetration and identify opportunities to grow their businesses.”

This is the third consecutive year Deloitte recognized Definitive Healthcare in its Technology Fast 500™. Definitive Healthcare previously ranked #152 in 2017 (with 707% 3-year revenue growth), and #184 in 2018 (with 528% 3-year revenue growth).

“When you’re a smaller business, it’s easier to experience higher rates of growth. Over the past three years, Definitive Healthcare has grown to surpass the $100 million mark, so we are incredibly proud to secure placement on Deloitte’s Fast 500 list yet again, particularly as we scale upward,” said Krantz.

Earlier this year Definitive was recognized, for the third consecutive year, for rapid growth by Inc. 5000 in its list of fastest-growing private companies in the U.S., and by the Boston Business Journal in its Fast 50. The Boston Business Journal also recently listed Definitive Healthcare as 2019’s #1 Best Place to Work in Massachusetts (Large Companies).

“Recognition from businesses like Deloitte is always an honor, and validates our company’s commitment to innovation,” Krantz continued. “In 2020, we are committed to expanding our product offerings based on our customers’ needs, as we continue to launch new, relevant, and integrated data assets and analytics offerings. Every day, we are focused on building the insights that ensure our customers, old and new, can reach their market potential.”

About Definitive Healthcare

Definitive Healthcare is the leading provider of data and intelligence on hospitals, physicians, and other healthcare providers. Its product suite provides the most comprehensive and highest quality data available anywhere on 8,800 hospitals and IDNs; 148,000 physician groups; 1.7 million physicians, nurses, and allied health professionals; 11,200 ambulatory surgery centers; 14,600 imaging centers; 91,600 long-term care facilities; 40,000 clinics; 1,400 ACOs and HIEs; more than 4 billion commercial medical and Rx claims; 115,000 clinical trials; and 900 Canadian hospitals. The company’s data provides its 2,200+ clients with the analytics and insight needed to effectively segment and research the healthcare provider market. Definitive Healthcare is backed by Advent International and Spectrum Equity. For more information, or to trial the service, visit https://www.definitivehc.com/.

Media Contact

Tory Waldron

PR Manager

twaldron@definitivehc.com

(781) 454-6822

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see http://www.deloitte.com/about to learn more about our global network of member firms.

Share article on social media or email:

Boehringer Ingelheim has deployed Genedata Selector to support the application of next generation sequencing (NGS) in cell line engineering, clone selection and adventitious agent detection workflows.

BASEL, Switzerland (PRWEB)
November 07, 2019

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced an expansion of its collaboration with Boehringer Ingelheim, a research-driven pharmaceutical company, to digitalize and automate complex cell line development processes. As part of this collaboration, Genedata Selector has been deployed to support the application of next generation sequencing (NGS) in cell line engineering, clone selection and adventitious agent detection workflows.

Many biopharma companies, like Boehringer Ingelheim, are using NGS-based approaches throughout bioprocess development to speed up workflows and create significant cost savings. Genedata Selector harmonizes and automates these NGS-based workflows by providing an integrated data management and analysis platform. Genedata Selector offers all the features required for deployment into regulatory environments in downstream biologics manufacturing.

The centralized approach to global data management provided by Genedata Selector facilitates collaboration among research groups and sites and reduces error-prone exchange of data files. With an easy-to-use interface and enterprise-wide access to experimental data in one secure system, Genedata Selector enables biopharma companies to increase the efficiency of their decision-making processes. For specific applications, such as NGS-based detection of adventitious agents, Genedata Selector also creates the opportunity for biopharma R&D organizations to become independent of external service providers and gain full control of data, resulting in tremendous savings in time and money.

“We are very excited about our partnership with Boehringer Ingelheim, an innovative leader in the biopharma industry,” said Othmar Pfannes, Ph.D., CEO of Genedata. “Genedata is committed to supporting our customers looking to automate and digitalize their bioproduction processes by providing the most advanced and innovative technologies for organizations to maximize their return.”

About Genedata

Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.

http://www.genedata.com

LinkedIn | Twitter | YouTube

Contact

Miles Fisher-Pollard

Genedata

Public Relations

Phone: +41 61 511 85 61

pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Share article on social media or email:

smarTours

NEW YORK (PRWEB)
November 07, 2019

Today, smarTours, the leading provider of value-driven international travel experiences to bucket list destinations, announced to commemorate Veterans Day they will be offering a 5 percent discount (up to a $235 value) for veterans and active military on its newly launched Battlefields of WWI & WWII tour. The discount can be used on any departing tour. The company is offering five Battlefields tours that depart April-October 2020. Travelers will journey through five European countries spanning both world wars and discover places that commemorate these world-changing events and honor fallen soldiers.

The 13-day tour visits historic locations across England, France, Belgium, Luxembourg, and Germany. Travelers will enjoy highlights such as London’s Imperial War Museum, Churchill War Room and Bunker, Normandy Beaches including Omaha Beach, Dunkirk shores, and the Maginot Line, among many other notable historical locations. Fittingly, this tour ends in Germany, where WWII ended and the Cold War began. A Berlin extension is available where travelers will tour notable locations across East and West Berlin as well as travel to the location of the Potsdam Conference.

“One of the top reasons our travelers give for wanting to travel internationally is to learn about the history of the destination. Our Battlefields tour makes it accessible and affordable for any history buff to reach often remote locations on their travel bucket list”, says Kendra Guild, smarTours Director of Product & Operations. “We feel it’s important to offer a discount to veterans and active military, so they can learn more about the history of those who served our country before them.”

The starting price for this airfare included 13-day tour is $3,999 or just $309 a day. Each tour includes first-class accommodations, ground transportation, English speaking guides, and many meals. A 3-day Berlin extension tour is available.

For more information please visit: https://smartours.com/western-europe/battlefields-of-wwi-wwii/

About smarTours:

smarTours is a leading provider of value-driven travel experiences to bucket list destinations worldwide. The company currently offers more than 50 guided tours to 62 countries across all continents. All smarTours include international airfare, hotels in convenient locations, knowledgeable English-speaking local guides, in-depth excursions and sightseeing, and many meals. Based in New York City, more than 225,000 travelers have taken a smarTours trip since the founding of the company in 1996.

Share article on social media or email:

“MSP and healthcare are growing markets, and together, we are zeroing in on what our team knows best.”

Hanover, MD (PRWEB)
November 07, 2019

With the Bureau of Labor Statistics expecting healthcare employment to grow 14 percent between 2018 and 2028, adding about 1.9 million jobs, healthcare will be a major focus for Allegis Global Solutions (AGS) in 2020 as AGS has recently acquired the Managed Services Provider (MSP) arm of Maxim Healthcare Services (Maxim).

This acquisition bolsters AGS’ well established healthcare client portfolio and will allow for increased targeted support of health and hospital systems, specifically in the acute and patient care sectors.

“We believe our industry-leading MSP solutions in this high-growth market segment will modernize the strategic value for companies in this niche space and bring recruitment innovation to the forefront. We are excited to position Shawn Lindsay as Sr. Executive, Healthcare Solutions to oversee this select group of accounts to concentrate on impacting the unique positive business outcomes of organizations in this space.”

— Steve Schumacher, Sr. Vice President, AGS

“MSP and healthcare are growing markets, and together, we are zeroing in on what our team knows best. With exceptional client service and growing industry knowledge, our team is primed to provide healthcare MSP clients with unmatched dedication and capability. You will not find a team more committed to understanding the nuances that drive your business, your market, or your customers.”

— Shawn Lindsay, Sr. Executive, Healthcare Solutions, AGS

For more information on Allegis Global Solutions and its industry-leading services, visit http://www.allegisglobalsolutions.com or follow @AllegisGlobal on Twitter.

About Allegis Global Solutions

Allegis Global Solutions is a leader in global talent solutions. To date, we support clients in more than 60 countries through regional hubs, matching our great people with businesses seeking to optimize their permanent and contingent workforce. We deliver scalable, flexible, and customized solutions, shaped around your unique business requirements and culture. We draw upon decades of industry expertise and market insight to design strategies that work. We develop innovative tools, products, and processes that deliver the results you seek. And we do all this better than anyone else. Our passion for talent is the driving force behind everything we do. We live to match exceptional organizations with outstanding people. By creating a culture devoted to great talent, we can deliver client-focused solutions that make a difference for your business.

Share article on social media or email:

Use Code FIFTYOFF

Our expert trainers narrate their procedures and we have a professional video team so the lessons are first rate! The course is sure to put providers on a path to be a local leader in regenerative therapies.

SCOTTSDALE, Ariz. (PRWEB)
November 07, 2019

R3 Stem Cell is now offering its comprehensive Online Stem Cell Training Course at 50% off through the rest of 2019. The code to use during checkout is FIFTYOFF and applies to both the one month access and the one year as well.

R3 is the nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures performed nationwide. A couple years ago, R3 began offering in person provider training workshops, which routinely achieve 5 star ratings from attendees. However, R3 understands how difficult it can be to carve out time from one’s practice (including travel) to gain the desired knowledge and skills to become a local leader in regenerative therapies.

The online course includes excellent lessons on musculoskeletal procedures, aesthetics and more. There are presentations on biologics as well such as stem cells, growth factors, cytokines and exosomes.

So what R3 accomplished with the online regenerative training is to place all the presentations and procedure videos from the in person training into the course. Providers can take the course anywhere, anytime and learn topics that include sales and marketing, biologic education, and lessons on supplements, PRP and ultrasound.

There are over 25 procedure videos, which include several types of administration. All types of providers will benefit from the course, including DO, MD, NP, ND, PA along with practice owners and administrators.

Because R3 offers the in person workshops frequently, the online content is updated a lot. This is exactly why the course is offered for either one month access or one year. Some providers will prefer to revisit the Course for a refresher and regular updates.

According to R3 CEO David Greene, “Our expert trainers narrate their procedures and we have a professional video team so the lessons are first rate! The course is sure to put providers on a path to be a local leader in regenerative therapies.”

Providers who complete the course receive a Certificate of Completion. For course registration, visit THIS PAGE or call (844) GET-STEM for additional information.

Share article on social media or email:

Top Advertising & Marketing Agencies 2019

Big Buzz was named a Top Colorado Agency with a 5.0 rating by Clutch, a DC-based B2B ratings and reviews organization. This accolade was based on Clutch’s extensive research and client interviews. Shortly thereafter, in August, the agency was honored with recognition as a Top Healthcare Digital Mark

DENVER (PRWEB)
November 06, 2019

Big Buzz continues to build upon a record year in 2019, significantly increasing revenues and staffing as it charges forward into healthcare and medical technology. The agency – which primarily serves the biosciences, specialty clinic and senior living industries – was also recognized for multiple awards, while team members spoke at prominent events nationwide.

In June, Big Buzz was named a Top Colorado Agency with a 5.0 rating by Clutch, a DC-based B2B ratings and reviews organization. This accolade was based on Clutch’s extensive research and client interviews. Shortly thereafter, in August, the agency was honored with recognition as a Top Healthcare Digital Marketing Agency by B2B titans UpCity.

Many of these accomplishments came in the wake of a significant rebrand, wherein the agency consolidated its industry-specialized brands Big Buzz Brands (dentistry) Bloom (senior living) and Viv (medical device) into the singular Big Buzz identity. The consolidation allowed the team to increase production and utilization by streamlining internal marketing efforts and reallocating bandwidth.

“When I founded the firm 12 years ago, I was inspired by other female entrepreneurs to scale the firm to more than $1 million in annual revenues. Last year for the first time, we joined the 1.7% of women-owned businesses that have broken through that glass ceiling, and this year we are grateful to be tracking to do the same.”

-Wendy O’Donovan Phillips, Big Buzz CEO

“The personal attention I receive from them is great—they’ve been a dream to work with. I can tell Big Buzz devotes their focus to our us. They’re highly engaged in the work and attentive to our needs,” said a Sales Manager at PreXion CBCT

At Big Buzz, our vision is to help people create marketing, careers and lives they never believed possible. It is our mission to offer healthcare organizations result-driven marketing that moves more quickly and easily to market than ever before, all with top-notch customer service. We are relentless about our commitment to agility so that we can help each client organization attract their ideal patients or clients and become more readily productive, profitable and successful.

Share article on social media or email:

AltMed Florida Dispensary Design

Our MÜV dispensaries are unlike anything in the state and we’re excited to invite licensed patients throughout Lee County and beyond to visit our newest state-of-the-art location in Fort Myers.

SARASOTA, Fla. (PRWEB)
November 06, 2019

AltMed Florida, one of the fastest growing Medical Marijuana Treatment Centers (MMTC) in Florida (source: OMMU), has announced the grand opening of its 10th MÜV™ Medical Cannabis Dispensary at 10 a.m. Saturday Nov.9 (pending final approvals) at 10993 Colonial Blvd., Suite 101 in Fort Myers, Florida.

AltMed’s MÜV Dispensary in Fort Myers, the company’s second to feature a drive-through window, is conveniently located near the Crossroads Shopping Center near State Highway 82. It will offer an extensive selection of award-winning products including flower, pre-rolls, a wide range of vaporizer pens, metered dose inhalers, topicals, oral sprays, patent-pending encapsulation formulations in its Tinctures, 72-Hour Transdermal patches and transdermal gels. MÜV is also recognized for having one of the widest selections of concentrates for patients needing macro-dosing options.

“Our dispensaries set the standard for quality products, service and overall patient experience at our current locations and we’re excited to offer our premium MÜV medical cannabis brand to even more people as we expand our presence in Southwest Florida,” said AltMed Florida CEO John Tipton. “Our MÜV dispensaries are unlike anything in the state and we’re excited to invite licensed patients throughout Lee County and beyond to visit our newest state-of-the-art location in Fort Myers.”

Like AltMed Florida’s nine other locations (Apollo Beach, Clearwater, Gainesville, Jacksonville/San Marco, Jacksonville Beach, Longwood/Orlando, Sarasota, Tampa and Wellington/West Palm), the new Fort Myers MÜV Dispensary stands out from others because it’s designed as a premium experience. Think Apple store, with a modern, open-concept design and expert staff with extensive training.

During the grand opening, all licensed Florida medical cannabis patients will receive 25 percent off their entire first purchase and the first 100 patients will receive a MÜV SWAG bag with their purchase. Patients can also order online at http://www.muvfl.com for express pickup or delivery.

The MÜV brand already has a wide following in other legal medical cannabis markets, including Arizona, where it has won five Best of Arizona medical cannabis awards. MÜV products are sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders – only products that license holders make themselves can be sold in their dispensaries.

For more information about the new ADA-compliant Fort Myers MÜV Medical Cannabis Dispensary, including hours and available MÜV products, visit http://www.MÜVFL.com.

AltMed Florida is on pace to open 40 MÜV Medical Cannabis Dispensaries across the state, all supplied by its 200,000-square-foot, state-of-the-art cultivation facility. Visit this link for images of AltMed Florida’s cultivation operations and watch this brief video to see what makes AltMed Florida and its MÜV™ Medical Cannabis Dispensaries stand out.

About Plants of Ruskin, LLC – d.b.a. AltMed Florida, LLC – With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.

About AltMed Enterprises – Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.

About MÜV™ – The MÜV brand of cannabis infused products was launched in Arizona in 2016 and quickly gained international attention and recognition. In its first six months alone, MÜV received four best of Arizona medical cannabis awards, including two first prizes for its proprietary Ethanol extractions that are the basis of all MÜV products.

Forward-Looking Statements – To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.

WCG_FDANews_Logo

FALLS CHURCH, Va. (PRWEB)
November 07, 2019

Understanding UDI in EU Device Regulations

An FDAnews Webinar

Thursday, Nov. 21, 2019, 1:30 p.m. – 3:00 p.m. EST

https://www.fdanews.com/understandudi

Are EU device and IV diagnostics sales in jeopardy?

It’s not a trick question. The last major compliance hurdle to new EU device regulations —UDI — is ahead, and many device and diagnostics makers simply aren’t prepared.

Not yet anyway.

Mark the calendar for Thursday, Nov. 21, when device regulation expert Dan O’Leary lays out the challenges of complying with unique device identification (UDI) rules … explains major variances from FDA regulations … and helps attendees meet the May 2020 deadline:

• 
  Overview of the EU’s UDI system
• Requirements for devices and packages
• The Basic UDI-DI: Its role and uses
• EU-MDR Article 120 transition requirements
• The European UDI workaround
• EU-MDR database elements
• EU-IVDR database elements
• Database translation issues

BONUS: Attendees will receive an Excel workbook to help identify the database elements and verify the requirements.

UDI compliance includes data elements, verifying correctness and update labels and translating and loading the database. Success demands a team effort. Take this opportunity to bring every member of the team up to speed.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Understanding UDI in EU Device Regulations

An FDAnews Webinar

Thursday, Nov. 21, 2019, 1:30 p.m. – 3:00 p.m. EST

https://www.fdanews.com/understandudi

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/understandudi

By phone: 888-838-5578 or 703-538-7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

SPH Analytics is an NCQA-Certified Survey Vendor for the CAHPS Survey and has administered the survey to health plans throughout the nation since the program’s inception in 1998.

These exemplary rankings are clear indicators of our clients’ dedication to the voice of the member, and we look forward to continuing to help support their success into 2020 and beyond.

ALPHARETTA, Ga. (PRWEB)
November 06, 2019

SPH Analytics, the top ranked member satisfaction measurement firm in the health plan market, announced today that 94% of the health insurance plans receiving the highest 4.5- to 5-point ratings in the 2019-2020 ratings for private, Medicare, and Medicaid health insurance plans, use SPH solutions according to reports recently released by the National Committee for Quality Assurance (NCQA).

Healthcare organizations, including 100% of the top 25 largest health plans in the nation, partner with SPH Analytics for complete healthcare survey management, patient/member outreach services, and powerful quality and cost analytics that empower them to take targeted actions to measurably improve patient experience, population health, and deliver better care.

NCQA’s Health Insurance Plan Ratings 2019-2020 list rated more than 1,000 private, Medicare, and Medicaid health insurance plans based on clinical quality, member satisfaction, and NCQA Accreditation Survey results. NCQA ratings classify plans into scores from 1.5 to 5.0, in 0.5 increments, with 5 being the highest performance rating.

The CAHPS® Survey is considered the most comprehensive tool available for assessing member experiences with their health plan. SPH Analytics is an NCQA-Certified Survey Vendor for the CAHPS Survey and has administered the survey to health plans throughout the nation since the program’s inception in 1998. Member satisfaction performance as measured in the CAHPS Survey represents 19% of a health plan’s rating.

“We recognize that it is difficult to provide exceptional member engagement and to drive strong loyalty. We applaud these highest performing plans who have prioritized understanding member experience, diving into root cause where there is opportunity to improve and driving impactful change. We are proud to partner with each of these top performing organizations and are grateful to serve as their partner in their journey to provide the highest member experience,” said Amy Amick, President and CEO of SPH Analytics. “These exemplary rankings are clear indicators of our clients’ dedication to the voice of the member, and we look forward to continuing to help support their success into 2020 and beyond.”

NCQA is a private, non-profit organization dedicated to improving healthcare quality. NCQA accredits and certifies a wide range of healthcare organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in healthcare.

CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ)

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

About SPH Analytics

SPH Analytics (SPH), a leader in healthcare analytics and population health management, empowers clients to analyze and interpret their clinical, financial, and consumer experience data to maximize their performance. SPH’s Population Care™, Population Value™, and Population Engage™ solutions are built on the innovative Nexus™ Platform, providing insights and impact to integrated health networks, ACOs, hospitals, ambulatory care providers, physician groups, and health plans. SPH’s quality measure dashboards, financial risk measurement, healthcare survey and patient outreach solutions, and consulting services empower clients to meet the Triple Aim by improving population health, reducing overall cost of care, and improving the patient experience.

SPH Analytics is a recognized leader in the industry, earning accolades as a top-ranked population health vendor by KLAS, top-ranked satisfaction measurement firm in the health plan market by Modern Healthcare, and ranked number one in MACRA and MIPS Support Technology for Value-Based Care by Black Book Research. SPH Analytics has been providing insights to clients for more than 35 years and serves clients in all 50 states, including 100% of the top 25 largest health plans. Corporate headquarters are in metro Atlanta. SPH Analytics is a portfolio company of the $3 billion STG Partners. For more information, call 1-866-460-5681 or visit SPHAnalytics.com.

Share article on social media or email: